
### [NCIT:C2853](http://purl.obolibrary.org/obo/NCIT_C2853)
**Label:** Papillary Adenocarcinoma

**Subclasses:** [NCIT:C46095](http://purl.obolibrary.org/obo/NCIT_C46095) (Solid Variant Thyroid Gland Papillary Carcinoma), [NCIT:C7645](http://purl.obolibrary.org/obo/NCIT_C7645) (Intracystic Papillary Breast Carcinoma), [NCIT:C27254](http://purl.obolibrary.org/obo/NCIT_C27254) (Papillary Eccrine Carcinoma), [NCIT:C7427](http://purl.obolibrary.org/obo/NCIT_C7427) (Thyroid Gland Diffuse Sclerosing Papillary Carcinoma), [NCIT:C6975](http://purl.obolibrary.org/obo/NCIT_C6975) (Papillary Renal Cell Carcinoma), [NCIT:C27890](http://purl.obolibrary.org/obo/NCIT_C27890) (Sporadic Papillary Renal Cell Carcinoma), [NCIT:C27937](http://purl.obolibrary.org/obo/NCIT_C27937) (Thymic Papillary Adenocarcinoma), [NCIT:C8377](http://purl.obolibrary.org/obo/NCIT_C8377) (Papillary Serous Cystadenocarcinoma), [NCIT:C4035](http://purl.obolibrary.org/obo/NCIT_C4035) (Thyroid Gland Papillary Carcinoma), [NCIT:C6256](http://purl.obolibrary.org/obo/NCIT_C6256) (Ovarian Serous Surface Papillary Adenocarcinoma), [NCIT:C9222](http://purl.obolibrary.org/obo/NCIT_C9222) (Hereditary Papillary Renal Cell Carcinoma), [NCIT:C9122](http://purl.obolibrary.org/obo/NCIT_C9122) (Stage III Thyroid Gland Papillary Carcinoma), [NCIT:C36085](http://purl.obolibrary.org/obo/NCIT_C36085) (Invasive Papillary Breast Carcinoma), [NCIT:C95967](http://purl.obolibrary.org/obo/NCIT_C95967) (Ampulla of Vater Invasive Papillary Adenocarcinoma), [NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern), [NCIT:C65204](http://purl.obolibrary.org/obo/NCIT_C65204) (Papillary Mucinous Cystadenocarcinoma), [NCIT:C35558](http://purl.obolibrary.org/obo/NCIT_C35558) (Tall Cell Variant Thyroid Gland Papillary Carcinoma), [NCIT:C3777](http://purl.obolibrary.org/obo/NCIT_C3777) (Papillary Cystadenocarcinoma), [NCIT:C54400](http://purl.obolibrary.org/obo/NCIT_C54400) (Nasopharyngeal Papillary Adenocarcinoma), [NCIT:C7438](http://purl.obolibrary.org/obo/NCIT_C7438) (Infiltrating Papillary Adenocarcinoma), [NCIT:C46004](http://purl.obolibrary.org/obo/NCIT_C46004) (Thyroid Gland Papillary Microcarcinoma), [NCIT:C5650](http://purl.obolibrary.org/obo/NCIT_C5650) (Papillary Lung Adenocarcinoma), [NCIT:C7695](http://purl.obolibrary.org/obo/NCIT_C7695) (Primary Peritoneal Serous Papillary Adenocarcinoma), [NCIT:C6267](http://purl.obolibrary.org/obo/NCIT_C6267) (Fallopian Tube Papillary Adenocarcinoma), [NCIT:C9134](http://purl.obolibrary.org/obo/NCIT_C9134) (Papillary Breast Carcinoma), [NCIT:C4182](http://purl.obolibrary.org/obo/NCIT_C4182) (Serous Surface Papillary Carcinoma), [NCIT:C27886](http://purl.obolibrary.org/obo/NCIT_C27886) (Type 1 Papillary Renal Cell Carcinoma), [NCIT:C5472](http://purl.obolibrary.org/obo/NCIT_C5472) (Gastric Papillary Adenocarcinoma), [NCIT:C27887](http://purl.obolibrary.org/obo/NCIT_C27887) (Type 2 Papillary Renal Cell Carcinoma), [NCIT:C123903](http://purl.obolibrary.org/obo/NCIT_C123903) (Childhood Thyroid Gland Papillary Carcinoma), [NCIT:C4190](http://purl.obolibrary.org/obo/NCIT_C4190) (Intraductal Papillary Breast Carcinoma), [NCIT:C9082](http://purl.obolibrary.org/obo/NCIT_C9082) (Stage II Thyroid Gland Papillary Carcinoma), [NCIT:C9083](http://purl.obolibrary.org/obo/NCIT_C9083) (Stage IV Thyroid Gland Papillary Carcinoma), [NCIT:C9081](http://purl.obolibrary.org/obo/NCIT_C9081) (Stage I Thyroid Gland Papillary Carcinoma), [NCIT:C37304](http://purl.obolibrary.org/obo/NCIT_C37304) (Multicentric Thyroid Gland Papillary Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 38.30%


